公司概覽
業務類別 Biotechnology
業務概覽 Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
公司地址 3027 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
電話號碼 +1 805 418-5006
傳真號碼 --
公司網頁 https://www.arcutis.com
員工數量 354
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Patrick E. Burnett, M.D. Executive Vice President and Chief Medical Officer 美元 504.20K 29/04/2025
Mr. Masaru Matsuda, J.D. Senior Vice President, General Counsel and Corporate Secretary 美元 465.47K 29/04/2025
Mr. Todd Franklin Watanabe Director, President and Chief Executive Officer 美元 660.87K 25/02/2026
Mr. L. Todd Edwards Executive Vice President and Chief Commercial Officer 美元 516.42K 29/04/2025
Ms. Latha Vairavan Principal Accounting Officer, Senior Vice President and Chief Financial Officer -- 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Keith R. Leonard, Jr Chairman of the Board 25/02/2026
Mr. Patrick J. Heron Independent Director 25/02/2026
Ms. Halley E. Gilbert Independent Director 25/02/2026
Ms. Terrie Curran Independent Director 25/02/2026
Mr. Todd Franklin Watanabe Director, President and Chief Executive Officer 25/02/2026
Dr. Howard G. Welgus, M.D. Independent Director 25/02/2026
Ms. Sue-Jean Lin Independent Director 25/02/2026
Ms. Neha Krishnamohan Independent Director 25/02/2026
Mr. Amit D. Munshi Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:49)
代號 名稱 佔比% 持有日期
XBIState Street® SPDR® S&P® Biotech ETF2.31%27/02/2026
IWOiShares Russell 2000 Growth ETF0.74%28/02/2026
IBBiShares Biotechnology ETF0.65%28/02/2026
SCHASchwab US Small-Cap ETF™0.44%28/02/2026
VTWOVanguard Russell 2000 ETF0.42%31/01/2026
VHTVanguard Health Care ETF0.26%31/01/2026
HQHabrdn Healthcare Investors0.24%31/01/2026
FESMFidelity Enhanced Small Cap ETF0.18%27/02/2026
FYCFirst Trust Small Cap Gr AlphaDEX® ETF0.16%26/02/2026
PSCPrincipal US Small Cap ETF0.13%28/02/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.12%28/02/2026
HQLabrdn Life Sciences Investors0.12%31/01/2026
LABUDirexion Daily S&P Biotech Bull 3X ETF0.10%26/02/2026
FYXFirst Trust Small Cap Core AlphaDEX® ETF0.09%26/02/2026
VTWGVanguard Russell 2000 Growth ETF0.08%31/01/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.06%27/02/2026
VFMOVanguard US Momentum Factor ETF0.05%31/12/2025
PRFZInvesco RAFI US 1500 Small-Mid ETF0.05%27/02/2026
PTHInvesco Dorsey Wright Healthcare MomtETF0.05%27/02/2026
SCHBSchwab US Broad Market ETF™0.05%28/02/2026
 1    2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.